Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of ciprofol for loss of consciousness in general anesthesia and postoperative recovery quality
ChiCTR2300078688Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in None (6 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: ED50 for loss of consciousness with ciprofol and ED95 for loss of consciousness with ciprofol. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2300078688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078688.